Cargando…
Intracellular Antibodies for Drug Discovery and as Drugs of the Future
The application of antibodies in cells was first shown in the early 1990s, and subsequently, the field of intracellular antibodies has expanded to encompass antibody fragments and their use in target validation and as engineered molecules that can be fused to moieties (referred to as warheads) to re...
Autor principal: | Rabbitts, T. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044824/ https://www.ncbi.nlm.nih.gov/pubmed/36975371 http://dx.doi.org/10.3390/antib12010024 |
Ejemplares similares
-
An antibody-drug conjugate with intracellular drug release properties showing specific cytotoxicity against CD7-positive cells
por: Zhang, Jing, et al.
Publicado: (2021) -
GPCRs in Intracellular Compartments: New Targets for Drug Discovery
por: Fasciani, Irene, et al.
Publicado: (2022) -
Challenges in Drug Discovery for Intracellular Bacteria
por: Tucker, Allison N., et al.
Publicado: (2021) -
Alkaloids in Future Drug Discovery
por: Ferreira, Maria-José U.
Publicado: (2022) -
Intracellular trafficking of new anticancer therapeutics: antibody–drug conjugates
por: Kalim, Muhammad, et al.
Publicado: (2017)